Searched over 200M research papers
10 papers analyzed
These studies suggest low HDL cholesterol is associated with increased risk of autoimmune disease, atherosclerosis, and certain cardiovascular conditions, while its role and impact can vary based on genetic, dietary, and regional factors.
20 papers analyzed
High-density lipoprotein (HDL) cholesterol is often referred to as "good cholesterol" because it helps remove other forms of cholesterol from the bloodstream. HDL carries cholesterol from other parts of your body back to your liver, which then removes the cholesterol from your body. However, low levels of HDL cholesterol can have significant health implications.
Low HDL cholesterol is strongly associated with an increased risk of coronary artery disease (CAD). Studies have shown that individuals with lower HDL levels tend to have a higher incidence of CAD, characterized by the buildup of plaque in the coronary arteries, which can lead to heart attacks and other cardiovascular events . This relationship is evident even in asymptomatic individuals, where low HDL levels correlate with increased carotid artery intima-media thickness, a marker of atherosclerosis.
While HDL cholesterol levels are inversely related to cardiovascular risk, the functionality of HDL particles is also crucial. HDL particles are involved in reverse cholesterol transport, anti-inflammatory processes, and antioxidative activities. However, simply raising HDL cholesterol levels has not proven to be an effective therapeutic target for reducing cardiovascular events, as HDL functionality varies significantly .
Recent research indicates that low HDL cholesterol levels are associated with a higher risk of developing autoimmune diseases. A large population-based study found that individuals with HDL cholesterol levels below 1.0 mmol/L (39 mg/dL) had a significantly higher risk of autoimmune diseases compared to those with higher HDL levels. This suggests that HDL may play a role in normal immune function, and low levels could impair this function, leading to autoimmune conditions.
Low HDL cholesterol has been linked to higher white blood cell counts, indicating a potential role in inflammation. Genetic studies have shown that individuals with genetically low HDL cholesterol have higher levels of leukocytes, including lymphocytes, monocytes, and eosinophils, which are markers of inflammation. This suggests a possible causal relationship between low HDL cholesterol and increased inflammatory responses.
The relationship between low HDL cholesterol and cardiovascular risk can vary significantly across different populations. For instance, in sub-Saharan Africa, low HDL levels are common but do not necessarily indicate increased cardiovascular risk as they do in European populations. This discrepancy is due to different associations between HDL and other cardiovascular risk factors, such as total cholesterol and adiposity.
In some populations, such as in Korea, there has been a significant increase in the prevalence of low HDL cholesterol over time. Factors such as body mass index, waist circumference, and lifestyle choices like physical activity and alcohol consumption have been associated with low HDL levels in these populations.
Low HDL cholesterol is a significant marker for various health risks, including cardiovascular disease, autoimmune diseases, and increased inflammatory markers. While raising HDL cholesterol levels alone has not proven to be an effective therapeutic strategy, understanding the functionality and broader implications of HDL can help in managing and mitigating these risks. It is essential to consider population-specific factors and individual health profiles when assessing the impact of low HDL cholesterol.
Most relevant research papers on this topic